🔵 This month, we continue to support #BlueMarch We are committed to supporting patients with metastatic colorectal cancer (mCRC) through the SHAPE program initiatives in collaboration with Digestive Cancers Europe (DiCE). Since its launch in 2018, the SHAPE program has been dedicated to empowering patients by providing a comprehensive suite of brochures designed to enhance their daily care needs. Co-created with patient experts, caregivers, and healthcare professionals, these resources reflect a commitment to collaboration and support. The newest addition to the SHAPE program is the educational guide, Adapting to metastatic Colorectal Cancer (mCRC). Check out the brochures 📚 designed with and for patients 👉 https://lnkd.in/eT7cpnwc We will keep supporting patients and their families throughout their cancer journey and will not give up the fight against colorectal cancer! #BlueMarch #WeAreServier #MovedByYou #ColorectalCancer #ECCAM2025
About us
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, Eastern Europe and Brazil. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com
- Website
-
https://servier.com
External link for Servier
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Suresnes
- Type
- Privately Held
Locations
-
Primary
Get directions
50 rue Carnot
Suresnes, 92150, FR
Employees at Servier
Updates
-
✨ We are proud to support World Adherence Day on 27 March 2025, an initiative by the World Heart Federation, driven through collaboration with partners from across the healthcare spectrum—scientific medical societies, advocacy foundations, patient organizations, the pharmaceutical sector, and many others. Learn more visit 🔗 https://lnkd.in/dq9qVSJ #WeAreServier #MovedByYou #AsOne #WorldAdherenceDay #DontMissAMoment
-
-
We are very proud to be the winner ✨of the 2025 Gallup Exceptional Workplace Award! 🙌🏼 We are the 1st French company to obtain this distinction for the second time. Above all, it rewards the involvement of all our teams 🏆 around the world. At Servier, we place the well-being of our employees 🤩 at the top of our priorities. We are dedicated to creating a happy and fulfilling work environment, and we have implemented numerous initiatives in recent years and since the beginning of Group transformation to support this goal. Our commitment to our employees is paying off. Once again, the Gallup annual survey has shown that our employees feel good at Servier. In fact, the engagement score rose from 3.91 in 2019 to 4.33 out of 5 in 2024. Thank you 🙏 to all our employees who are committed to therapeutic progress to serve patient needs! Learn more about this award 👉 https://lnkd.in/eHbgJST9 #ExceptionalTeams #MovedByYou #WeAreServier
-
-
Servier reposted this
Join us at BIO-Europe Spring as Anne Dagallier, Business Development Director Global Lead Oncology of Servier, takes the presenting stage. Don’t miss this opportunity to hear firsthand how they are shaping the future of biotech! 🤝 Register now and start engaging: https://lnkd.in/e5nE43yr 📅 BIO-Europe Spring | March 17–19, 2025 📍 Milan, Italy
-
We will attend BIO Europe Spring in Milan. This event is a unique opportunity to engage with other professionals, learn about the latest trends, and showcase our expertise. We look forward to connecting with other industry peers, sharing our latest research, and exploring new partnering opportunities. Don’t miss our company presentation by Anne Dagallier, Dr., Business Development, Global Lead Oncology, on March 17, 3:30 -3:45 pm (CET) #BIOEuropeSpring #partner #collaboration #biotech #HealthcareInnovation EBD Group
-
-
📣 Our 2023-2024 Integrated Annual Report is now available! 💪 We are excited to share our annual report, showcasing our ongoing commitment to innovation, patient care, and corporate responsibility. This year’s edition highlights: ✅ Alongside key achievements in our various therapeutic areas, this year marked the celebration of our 70th anniversary. ✅ Research & Development: Close to 20% of brand-name revenue reinvested in R&D each year, with a pipeline of 34 clinical projects, and 22 research projects (February 2025). ✅ Our 3 therapeutic areas: Oncology, Cardiometabolism & venous diseases, and Neurology. Discover our full report and explore our initiatives and ambitions for the future 👉 https://lnkd.in/etra4jKq #WeAreServier #MovedByYou #IntegratedAnnualReport
-
👩🔬 This International Women’s Day, let's celebrate the incredible women shaping the future of science, technology, engineering, and mathematics (STEM)! Despite their remarkable contributions, women remain underrepresented in STEM fields, facing barriers that hinder progress, recognition, and equality. 💡 Did you know? 📌 Gender bias continues to affect funding, career progression, and recognition in science, limiting opportunities for women despite them having equal capabilities. 📌 Diverse research teams drive better innovation, stronger solutions, and a more inclusive scientific landscape. From our “Proud To Be A Science Woman” campaign launched on social media, involving our employees to promote role models and inspiring career paths, to an engaging live event on YouTube featuring experts and female leaders aimed at sharing actionable strategies and testimonies in March, let’s keep pushing for a more inclusive and innovative world! 💬 Watch the replay of our Live on YouTube: “Women in science: fostering innovation in tech and science companies! “👉 https://lnkd.in/e2tYvsTA #WeAreServier #IWD2025 #WomenInScience
-
-
-
-
-
+1
-
-
To mark Rare Disease Day 💙💜💚, we had the pleasure of speaking 🗣️ with Nelly! Nelly has lived with a rare disease her whole life. She is also a big advocate online for chronic illnesses, especially rare ones. 🎥 Watch her inspiring story on our Instagram account and get her perspective on the fight against cancer 👉 https://lnkd.in/easRPCbz You can also find Nelly @chronically_nell on Instagram #RareDiseaseDay #ShareYourColours #LightUpForRare #WeAreServier #MovedByYou
-
2 hours left... Join us at 11:30 📍 Live on YouTube: https://lnkd.in/e2tYvsTA
👩⚕️ Tomorrow, join us for an inspiring live webinar: Women in science: fostering innovation in tech and science companies! In this webinar, we’ll have 🎤 two roundtables (30 min each), animated by Natasha Bibi-Derenne, exploring how women are driving change in STEM: ❓ First panel: "Bridging the gender gap in science: opportunities and challenges" (11:30am – 12pm) – with Susan Pandya, M.D., Soraya Ramoul Blegvad, and David HINDLEY ❓ Second panel: "Driving inclusion in science and tech industries: leadership and innovation" (12pm – 12:30pm CET) with Virginie Dominguez, Hani Friedman Bouganim, and Emmanuelle Larroque. 📆 March 6, 11:30 AM – 12:30 PM CET 📍 Live on YouTube: https://lnkd.in/e2tYvsTA #WeAreServier #MovedByYou #IWD2025 #WomenInSTEM #AccelerateAction
-
-
👩⚕️ Tomorrow, join us for an inspiring live webinar: Women in science: fostering innovation in tech and science companies! In this webinar, we’ll have 🎤 two roundtables (30 min each), animated by Natasha Bibi-Derenne, exploring how women are driving change in STEM: ❓ First panel: "Bridging the gender gap in science: opportunities and challenges" (11:30am – 12pm) – with Susan Pandya, M.D., Soraya Ramoul Blegvad, and David HINDLEY ❓ Second panel: "Driving inclusion in science and tech industries: leadership and innovation" (12pm – 12:30pm CET) with Virginie Dominguez, Hani Friedman Bouganim, and Emmanuelle Larroque. 📆 March 6, 11:30 AM – 12:30 PM CET 📍 Live on YouTube: https://lnkd.in/e2tYvsTA #WeAreServier #MovedByYou #IWD2025 #WomenInSTEM #AccelerateAction
-